Redefining osteoporosis treatment: who to treat and how long to treat
نویسندگان
چکیده
منابع مشابه
Redefining osteoporosis treatment: Who to treat and how long to treat.
Osteoporosis is a common disease that is associated with increased risk of fractures and serious clinical consequences. Bone mineral density (BMD) testing is used to diagnose osteoporosis, estimate the risk of fracture, and monitor changes in BMD over time. Combining clinical risk factors for fracture with BMD is a better predictor of fracture risk than BMD or clinical risk factors alone. Metho...
متن کاملPremenopausal osteoporosis: how to treat?
There is no agreement in defining osteoporosis in premenopausal women and diagnosis must be done carefully and not based on densitometric parameters. One must take into account the presence of other risk factors and history of fragility fractures, diseases or drugs that cause bone loss. Over 50% of premenopausal women with osteoporosis will have a secondary cause, with the remainder diagnosed w...
متن کاملHypertensive emergency and severe hypertension: what to treat, who to treat, and how to treat.
Remember to treat patients, not numbers. Use fast acting shortterm medicines only when convincing evidence of rapidly evolving end-organ damage is present. For all patients, emergent or asymptomatic, the treatment goal is long-term control of hypertension. Potent IV agents for the im-mediate control of elevated blood pressure need to be used cautiously,bearing in mind both the side effects and ...
متن کاملTreatment of osteoporosis: why, whom, when and how to treat.
Endocrine Unit, Austin and Repatriation Medical Centre, Melbourne, VIC. Ego Seeman, BSc, FRACP, MD, Professor of Medicine and Endocrinologist. Garvan Institute of Medical Research, St Vincent's Hospital, Sydney, NSW. John A Eisman, FRACP, PhD, Professor of Medicine, Endocrinologist and Director, Bone and Mineral Research Program. Reprints will not be available from the authors. Correspondence: ...
متن کاملPulmonary hypertension, how to diagnose and who to treat?
Pulmonary arterial hypertension is a fatal disease with an estimated survival rate of only 50% after 5 years [1]. Over the last years, knowledge in the field of pulmonary hypertension has grown consistently and significantly. New diagnostic tools, as well as the efficacy of new medications and drug combinations, have been described. How to define and diagnose pulmonary arterial hypertension is ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Arquivos Brasileiros de Endocrinologia & Metabologia
سال: 2006
ISSN: 0004-2730
DOI: 10.1590/s0004-27302006000400015